Common questions about Grastek (FAQ)
Q: Is Grastek the same kind of treatment as allergy shots?
Grastek is a type of Allergen Immunotherapy (AIT) called Sublingual Immunotherapy (SLIT) because it is a tablet dissolved under the tongue. Traditional allergy shots, or Subcutaneous Immunotherapy (SCIT), are another method of AIT. Regulatory information indicates that Grastek is not to be taken in combination with other forms of allergen immunotherapy, as this may increase the likelihood of experiencing adverse reactions.
Q: Does Grastek contain any food allergens like nuts or gluten?
Official product documents list the active ingredient (Timothy Grass Pollen) and inactive ingredients (excipients), including fish gelatin, mannitol, and sodium hydroxide. While the official ingredient list does not specifically mention or exclude nuts or gluten, if a patient has known hypersensitivity to any of the ingredients, a discussion with a healthcare provider is noted.
Q: Is Grastek a cure for grass pollen allergy?
Regulatory documents classify Grastek as an immunotherapy intended to treat grass pollen-induced allergic rhinitis. This type of treatment is designed to induce immune tolerance over time and is not intended for the immediate relief of symptoms. Clinical studies focused on demonstrating its ability to reduce symptoms and the need for relief medications during the grass pollen season.
Q: Can Grastek be used to treat severe asthma?
No. Official product documents state that Grastek is contraindicated (must not be used) in patients with severe, unstable, or uncontrolled asthma. It is indicated for allergic rhinitis (hay fever) with or without eye symptoms in certain eligible patients.
Q: What are the most common reasons a doctor would prescribe Grastek?
Grastek is officially indicated for treating grass pollen-induced allergic rhinitis (hay fever), which may include conjunctivitis (allergic eye symptoms). It is typically prescribed after testing confirms a sensitivity to Timothy grass pollen or cross-reactive grass pollens. It may be considered for patients whose symptoms are not adequately controlled by standard allergy medications like antihistamines or nasal sprays.
Q: How quickly does Grastek start to have an effect?
Grastek is not intended for the immediate relief of allergic symptoms, as it is a long-term immunotherapy treatment. Official administration guidelines state that treatment should be initiated at least 12 weeks before the start of the expected grass pollen season. Clinical studies evaluated effectiveness based on results measured over the course of an entire pollen season, as it is not for immediate relief.
Q: Are there any drug interactions with common cold medicines and Grastek?
The official prescribing information lists specific interactions with certain drugs, such as beta-blockers and some antidepressants, that could interfere with emergency allergic treatment. General cold medicines like decongestants are not typically listed as specific pharmacodynamic interactions in the regulatory documents, though reviewing all current medications with a healthcare provider is part of managing treatment.
Q: Is Grastek available in generic form?
Grastek is currently only available as the brand-name product. According to official drug registers, no generic equivalent of this standardized allergenic extract has been approved at this time.
Q: Is Grastek considered a biologic drug?
Grastek is classified by regulatory authorities as a standardized allergen extract product. Because it is derived from a natural source (Timothy grass pollen) and works by modulating the immune system, it is regulated by the FDA’s Center for Biologics Evaluation and Research (CBER) in the United States.
Q: Are there special monitoring requirements for children taking Grastek?
Yes, there are specific administration requirements for children. Official regulatory documents require that children must be supervised by an adult when taking the tablet daily. The very first dose must also be administered in a healthcare setting under the observation of a physician, a rule that applies to all patients regardless of age.
Q: Does Grastek stop working if you stop taking it suddenly?
Official guidance addresses interruptions in treatment, noting that if the daily tablet is stopped for more than seven days, a healthcare provider should be consulted before resuming. Evidence from clinical studies showed that after taking the tablet for three full years, the therapeutic benefit was sustained throughout the next grass pollen season, even after discontinuation.
Q: Is Grastek only prescribed by specialists?
Official labeling indicates that the first dose of Grastek should be administered by a physician in a healthcare setting. Regulatory sources note that the prescribing clinician should have adequate training and experience in managing allergic diseases, which often points toward an allergist or similarly trained specialist.
Q: Are there any specific lifestyle changes needed while on Grastek?
Yes, there are specific rules related to administration and oral health. Patients must avoid eating or drinking for at least five minutes after placing the tablet under the tongue. Treatment must also be temporarily stopped if a patient has any inflammation, sores, or cuts in the mouth, or following dental surgery, and should only resume once the mouth has fully healed.
Q: Are there warnings about Grastek and dental procedures?
Yes. Official safety information indicates that Grastek treatment must be temporarily withheld following any major dental procedure, such as a dental extraction or oral surgery. Treatment should also be stopped if you have mouth sores or cuts, and only resumed once the oral cavity has completely healed.
Q: What is the main goal of treatment with Grastek?
The main goal, as described in official labeling, is to provide immunotherapy for grass pollen-induced allergic rhinitis. This is intended to address the underlying allergic cause, resulting in a reduction in symptoms and lessening the patient's need for symptom-relieving allergy medications during the grass pollen season.
Q: Does Grastek protect against all types of grass pollen?
The active ingredient in Grastek is derived specifically from Timothy grass pollen. Official indications state that it is used for patients confirmed to be allergic to Timothy grass or other grass pollens that are known to cross-react with Timothy grass, which includes several common types like perennial rye and Kentucky blue grass.
Q: Can Grastek be used by someone who is pregnant or breastfeeding?
According to official product information, the available human data are insufficient to definitively establish the presence or absence of risk during pregnancy or breastfeeding. Use during these periods is generally advised only if clearly needed. A healthcare provider should evaluate the potential benefits and risks before starting or continuing treatment, as data is limited.
Q: What happens if I forget to swallow the tablet right away?
The official administration instructions require patients to keep the tablet under the tongue and refrain from swallowing for at least one minute to ensure proper absorption. Regulatory documents do not specifically detail the consequences if the tablet is swallowed immediately, but following the one-minute restriction is required for appropriate use.
Q: Can I stop taking my antihistamines once I start Grastek?
Clinical studies evaluated the benefit of Grastek by measuring the reduction in the use of allergy symptom-relieving medications like antihistamines. Official product information confirms this potential reduction, but adjustments to existing allergy medication are managed by a clinician, as official product information does not provide specific advice on when to stop or continue.
Q: Does Grastek affect the results of a blood test?
The way Grastek works is by changing the immune response, which includes increasing the levels of certain substances in the blood, such as allergen-specific IgG4 antibodies. While these changes can be measured in specialized blood tests, official information does not indicate that Grastek interferes with general blood chemistry or standard diagnostic blood tests.
Q: Do studies show if Grastek is more effective for some patients than others?
Regulatory documents summarize the clinical trials by showing the overall effectiveness of Grastek across the general study population, which included adults and children within the approved age range. The official prescribing information does not provide specific subgroup comparisons regarding whether the treatment is significantly more or less effective for one particular group of patients compared to another.
